A number of new drugs to treat Covid are due to hit the market soon. The availability of non-vaccine therapy will be attractive to people who have been reluctant to receive the vaccination as well as those who are vaccinated but worried they have had a break-through infection. It is important that the patient be given access to these therapies but just as important to make sure they are not being overused.
Araya is already putting in place protocols to manage these new therapies before payors see an unanticipated jump in utilization. If you are an Araya client, your account service team will be contacting you with our recommendations. If you are not a current client and would like to learn more about how you can reduce risk associated with this new therapy, please contact us.
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have
Shopping Basket
More Information?
Fill out your details and we will get back to you as soon as possible.
Managing the Cost of New Covid Treatments
A number of new drugs to treat Covid are due to hit the market soon. The availability of non-vaccine therapy will be attractive to people who have been reluctant to receive the vaccination as well as those who are vaccinated but worried they have had a break-through infection. It is important that the patient be given access to these therapies but just as important to make sure they are not being overused.
Araya is already putting in place protocols to manage these new therapies before payors see an unanticipated jump in utilization. If you are an Araya client, your account service team will be contacting you with our recommendations. If you are not a current client and would like to learn more about how you can reduce risk associated with this new therapy, please contact us.
See more news
Government Solution Not Needed to Reduce Drug Costs
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
Transparent Pharmacy Benefits Are Possible
In a recent article at BenefitsPRO, Dan Cook talks about the movement to have employers “rise up and fight their own battles with the drug
The Real Issues With Prescription Drug Costs
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have